José Victor de Oliveira Santos

José Victor de Oliveira Santos

Auto-generated profile, based on publicly available information

José Victor de Oliveira Santos

Postgraduate Program in Pharmaceutical Sciences, Laboratory of Toxicological Genetics, Federal University of Piaui, Teresina,Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2018 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
RLRosália Maria Tôrres de Lima
Rosália Maria Tôrres de Lima
ARAntonielly Campinho dos Reis
Antonielly Campinho dos Reis
AMAg‐Anne Pereira Melo de Menezes
Ag‐Anne Pereira Melo de Menezes
JSJosé Victor de Oliveira Santos
José Victor de Oliveira Santos
JFJosé Williams Gomes de Oliveira Filho
José Williams Gomes de Oliveira Filho
AMAna Amélia de Carvalho Melo‐Cavalcante
Ana Amélia de Carvalho Melo‐Cavalcante

1 December 2017 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
JFJosé Williams Gomes de Oliveira Filho
José Williams Gomes de Oliveira Filho
MIMd. Torequl Islam
Md. Torequl Islam
EAEunus S. Ali
Eunus S. Ali
SUShaikh Jamal Uddin
Shaikh Jamal Uddin
JSJose Victor de Oliveira Santos
Jose Victor de Oliveira Santos
AMAna Amélia de Carvalho Melo-Cavalcante
Ana Amélia de Carvalho Melo-Cavalcante

4 July 2018 in Current Drug Metabolism
Verified
Journal Article
Closed access
PDF file
MIMd. Torequl Islam
Md. Torequl Islam
STShams Tabrez
Shams Tabrez
NJNasimudeen R. Jabir
Nasimudeen R. Jabir
MAMurtaza Ali
Murtaza Ali
Mohammad KamalMohammad Kamal
Mohammad Kamal
ACAna Amelia de Carvalho Melo Cavalcante
Ana Amelia de Carvalho Melo Cavalcante
The popular drink, coffee (Coffea arabica) is under the great attention of late because of its promising pharmacological potential. Caffeine (the major constituent of coffee) is known for its prominent psychoactive impact. This review aims at highlighting the therapeutic potentials of caffeine and other five coffee components viz. caffeic acid, chlorogenic acids, cafestol, ferulic acid and kahweol and their suggested mechanisms of action. A number of pharmacological activities are attributed to these components that include anti-oxidant, anti-inflammatory, immunomodulatory, anti-microbial, anti-cancer, cardioprotective and neuroprotective effects. In addition, osteogenesis (kahweol), anti-diabetic (caffeine, chlorogenic acid, and ferulic acid) and hepatoprotective (chlorogenic acid) activities have also been reported by some of these components in the scientific literature. On the other hand, caffeine has also been noted for adverse effect on the development of the brain at early stages and reproductive systems. In conclusion, more pre-clinical and clinical trials are recommended to investigate the safety profiles of these coffee components.

14 February 2019 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MAMarcus V.O.B. Alencar
Marcus V.O.B. Alencar
MIMd. Torequl Islam
Md. Torequl Islam
EAEunus S. Ali
Eunus S. Ali
JSJosé V.O. Santos
José V.O. Santos
MPMárcia F.C.J. Paz
Márcia F.C.J. Paz
ACAna A.C.M. Cavalcante
Ana A.C.M. Cavalcante
Background: Phytol have various pharmacological activities such as antimicrobial, cytotoxic, antitumoral, antimutagenic, anti-atherogenic, antidiabetic, lipid-lowering, antispasmodic, antiepileptic, antinociceptive, antioxidant, anti-inflammatory, anxiolytic, antidepressant and immunoadjuvant. Several studies point to an association of phytol with implications for apoptosis and necrosis at cellular levels in cancer, yet no clear conclusions were drawn. Method: To clarify this, we conducted a meta-analysis of non-clinical studies of phytol and its associations with toxicity and cytotoxicity emphasizing the mechanisms of apoptosis and necrosis induction and its importance in tumor therapy. Relevant studies were systematically searched in PubMed and Web of Science. The association between phytol and cyto-/toxicity was assessed by odds ratio (ORs) and 95% confidence intervals (CI). Twentythree studies were finally included in the meta-analysis. A significant association between phytol and toxicity (OR: 1.47; 95% CI = 0.86–2.48) was found among in vivo studies and cytotoxicity (OR: 1.81; 95% CI = 1.12– 2.65, p<0.05) in in vitro and ex vivo studies. In in vitro studies, 24% of them indicate that phytol at high doses induces apoptosis by several mechanisms; while about 40% of ex vivo studies indicate that phytol induces reactive oxygen species generation. But, Phytol does not act as a direct oxidant, unlike its metabolite phytanic acid. The 24% of in vivo studies also highlighted the mechanisms for apoptosis-like including expression of Bcl2 protein or mutations in pro-apoptotic protein Bax. Of them, 8% studies show necrosis and hepatotoxicity. However, in 24% of the articles, the mechanisms of toxicity and cytotoxicity are still not well elucidated. Conclusion: This study confirms that the association between phytol and cyto-/toxicity depends on the dose/concentration used in the given experimental conditions. Thus, there are still great prospects for new research aimed at the use of phytol and its metabolite as anticancer agents.

1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
AMAna Amélia de Carvalho Melo-Cavalcante
Ana Amélia de Carvalho Melo-Cavalcante
LSLeonardo da Rocha Sousa
Leonardo da Rocha Sousa
MAMarcus Vinícius Oliveira Barros Alencar
Marcus Vinícius Oliveira Barros Alencar
JSJosé Victor de Oliveira Santos
José Victor de Oliveira Santos
AMAna Maria Oliveira da Mata
Ana Maria Oliveira da Mata
JSJoão Marcelo de Castro e Sousa
João Marcelo de Castro e Sousa
Cancer development has been directly related to oxidative stress. During chemotherapy, some cancer patients use dietary antioxidants to avoid nutritional deficiencies due to cancer treatment. Among the antioxidants consumed, there are vitamins, including retinyl palmitate (PR) and ascorbic acid (AA), which have the capacity to reduce free radicals formation, protect cellular structures and maintain the cellular homeostasis. This systematic review evaluated the antioxidant and antitumor mechanisms of retinol palmitate (a derivative of vitamin A) and/or ascorbic acid (vitamin C) in cancer-related studies. Ninety-seven (97) indexed articles in the databases PubMed and Science Direct, published between 2013 and 2017, including 23 clinical studies (5 for every single compound while 13 in interaction) and 74 non-clinical studies (37 for retinol palmitate, 36 for ascorbic acid and 1 in interaction) were considered. Antioxidant and antitumor effects, with controversies over dosage and route of administration, were observed for the test compounds in their isolated form or associated in clinical studies. Prevention of cancer risks against oxidative damage was seen in lower doses of retinol palmitate and/or vitamin C. However, at high doses, they can generate reactive oxygen species, cytotoxicity and apoptosis in test systems. Non-clinical studies using cell lines have allowed understanding the mechanisms related to antioxidants and antitumor effects of the isolated compounds, however, studies on vitamin interactions, acting as antioxidants and/or antitumor are still rare and controversial. More studies, mainly related to modulation of antineoplastic drugs are needed for understanding the risks and benefits of their use during treatment in order to achieve effectiveness in cancer therapy and patient's quality of life.

1 April 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
DGDébora Cássia Vieira Gomes
Débora Cássia Vieira Gomes
MAMarcus Alencar
Marcus Alencar
ARAntonielly Campinho dos Reis
Antonielly Campinho dos Reis
RLRosália Maria Torres de Lima
Rosália Maria Torres de Lima
JSJosé Victor de Oliveira Santos
José Victor de Oliveira Santos
ACAna Amélia de Carvalho Melo Cavalcante
Ana Amélia de Carvalho Melo Cavalcante
Biologically active compounds from species of the phylum Basidiomycota have been shown a wide range of pharmacological activities and provide a vast reservoir of potential innovational drugs. The aim of this review is to discuss some mechanisms of action involved in antioxidant, anti-inflammatory and cytotoxic/antitumoral activities attributed to the bioactive compounds from species of the phylum Basidiomycota. We show that isolated compounds from extracts, secondary metabolites and polysaccharides that presented antioxidant properties have mechanisms of action involved in the elimination/capture of free radicals and reduction of lipid peroxidation. Also, some bioactives with anti-inflammatory activity were reported to enhance innate and cell-mediated immune responses. Finally, compounds that presented cytotoxic/antitumoral activity induces increased free radical production, collapse of the mitochondrial membrane potential and increased expression of proteins responsible for cell cycle arrest and apoptosis. Investigating the mechanisms of action of biologically active compounds will facilitate further efforts to accelerate the discovery of novel therapeutic strategies.